Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zibotentan in Hormone Resistant Prostate Cancer with Bone Metastases
NCT00554229Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Nov 2007
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 31
01
Overview
A Phase 3 trial of zibotentan in prostate cancer (PCa), sponsored by AstraZeneca. Started Nov 2007; status: completed.
02
Drugs
zibotentan
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00554229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00554229.